Sandu Phytoceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-05-2024
- Paid Up Capital ₹ 0.10 M
as on 23-05-2024
- Company Age 2 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Sandu Phytoceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shashank Sandu and Umesh Sandu serve as directors at the Company.
- CIN/LLPIN
U24230GA2022PTC015422
- Company No.
015422
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2022
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
North Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sandu Phytoceuticals Private Limited offer?
Sandu Phytoceuticals Private Limited offers a wide range of products and services, including Ayur, Chandanasava, Menthol Essential Aromatic Oil, Chaulmoogra Oil, Kadha, Cancer Herbal Medicine, Gastrointestinal Drugs, Acidity Care Drops, Buds, Infertility Ayurvedic Treatment.
Who are the key members and board of directors at Sandu Phytoceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashank Sandu  | Nominee Director | 27-Jul-2022 | Current |
| Umesh Sandu | Nominee Director | 27-Jul-2022 | Current |
Financial Performance of Sandu Phytoceuticals.
Enhance accessibility to Sandu Phytoceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sandu Phytoceuticals?
Unlock access to Sandu Phytoceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sandu Pharmaceuticals LimitedActive 39 years 1 monthShashank Sandu and Umesh Sandu are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sandu Phytoceuticals?
Sandu Phytoceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sandu Phytoceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sandu Phytoceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
